Skip to content

Medical-device intelligence

Randox Laboratories Ltd.: FDA clearances and recalls

Research Randox Laboratories Ltd. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

115 clearance records and 79 recall records in the covered releases, across 1 source company names and 82 product codes. Dated history runs from Oct 15, 1992 to Jun 7, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

194 matching records
Device / recordCompany in FDA recordSourceSource date
Chemistry QC Premium Plus, Cat. No. LAL4213, GTIN 05055273209006 - Product Usage: This product is intended for in vitro diagnostic use, in the qu…Z-1547-2020 · JJYRandox Laboratories Ltd.RecallMar 20, 2020FDA record creation date
Liquid Clinical Chemistry Control, Catalogue Number: LAE4217, Size: 12 x 5 mlZ-1100-2020 · JJYRandox Laboratories Ltd.RecallFeb 6, 2020FDA record creation date
Rheumatoid Factor Standard (RF CAL) Catalogue Number: RF2301 GTIN: 05055273205039 Product Usage: The Randox Rheumatoid Factor Latex-Enhanced Imm…Z-0282-2020 · DHRRandox Laboratories Ltd.RecallNov 4, 2019FDA record creation date
Liquid Protein Calibrators (SP CAL (LIQ)) Catalogue Number: IT2691 GTIN: 05055273204032 Product Usage: Liquid Protein Calibrators are intended fo…Z-0283-2020 · JIXRandox Laboratories Ltd.RecallNov 4, 2019FDA record creation date
Randox Urinalysis Control Level 2 (IVD) Ref: UC5034 - Product Usage: Product is intended for in vitro diagnostic use in the quality control of…Z-2557-2019 · JJWRandox Laboratories Ltd.RecallSep 23, 2019FDA record creation date
This is an in vitro diagnostic product intended for use as a calibration serum in clinical chemistry assays. Randox calibration sera contain 42 a…Z-2490-2019 · JIXRandox Laboratories Ltd.RecallSep 7, 2019FDA record creation date
Liquid Cardiac Control, Model Nos. CQ5051, CQ5052, CQ5053Z-1785-2019 · JJYRandox Laboratories Ltd.RecallJun 14, 2019FDA record creation date
G-6-PDH Deficient Control (G-6-PDH CONTROL D), Catalogue Number PD2617 Product Usage: This product is intended for in vitro diagnostic use, in t…Z-1254-2019 · JBLRandox Laboratories Ltd.RecallMay 3, 2019FDA record creation date
G-6-PDH Normal Control (G-6-PDH CONTROL N), Catalogue Number PD2618 Product Usage: This product is intended for in vitro diagnostic use, in the …Z-1255-2019 · JBLRandox Laboratories Ltd.RecallMay 3, 2019FDA record creation date
Immunoassay Premium Controls, Model Numbers IA2633 and IA2638 Product Usage: This product is intended for in vitro diagnostic use, as assayed qu…Z-1105-2019 · JJYRandox Laboratories Ltd.RecallApr 8, 2019FDA record creation date
Immunoassay Premium Plus Controls, Model Numbers IA3109 and IA3112 Product Usage: This product is intended for in vitro diagnostic use, as assay…Z-1106-2019 · JJYRandox Laboratories Ltd.RecallApr 8, 2019FDA record creation date
Liquid Immunoassay Premium Controls, Model Number LIA3105 Product Usage: This product is intended for in vitro diagnostic use, as assayed qualit…Z-1107-2019 · JJYRandox Laboratories Ltd.RecallApr 8, 2019FDA record creation date
Randox Blood Gas Control Level 2 -Model BG5002. In-vitro Diagnostic Quality control of Blood Gas analysis This product is intended for in vitro …Z-1057-2019 · JJYRandox Laboratories Ltd.RecallMar 26, 2019FDA record creation date
Fructosamine Calibrator, FR2993 This product is intended for in vitro use in the calibration of the Randox Liquid Fructosamine assay on clinical…Z-1016-2019 · JITRandox Laboratories Ltd.RecallMar 15, 2019FDA record creation date
Fructosamine Control 1, FR2994 This product is intended for in vitro use in the calibration of the Randox Liquid Fructosamine assay on clinical…Z-1017-2019 · JJXRandox Laboratories Ltd.RecallMar 15, 2019FDA record creation date
Fructosamine Control 3, FR2996 This product is intended for in vitro use in the calibration of the Randox Liquid Fructosamine assay on clinical…Z-1018-2019 · JJXRandox Laboratories Ltd.RecallMar 15, 2019FDA record creation date
Randox CALCIUM (Ca) Colorimetric Method RX Series Cat. No. CA 3871, R1. Arsenazo Reagent 9 x 51ml GTIN: 05055273200904Z-0839-2019 · CJYRandox Laboratories Ltd.RecallFeb 15, 2019FDA record creation date
Randox CALCIUM (Ca) COLORIMETRIC METHOD RX DAYTONA PLUS Cat. No. CA 8309 R1, Arsenazo Reagent 4 x 20 ml GTIN: 05055273208368Z-0840-2019 · CJYRandox Laboratories Ltd.RecallFeb 15, 2019FDA record creation date
SP CAL (LIQ), REF IT2692 This product is intended for in vitro diagnostic use with Randox Alpha-1-Antitrypsin, Alpha-1-Acid Glycoprotein, IgA, …Z-0660-2019 · JIXRandox Laboratories Ltd.RecallDec 21, 2018FDA record creation date
Liquid Cardiac Control, CQ5051Z-0380-2019 · JJYRandox Laboratories Ltd.RecallNov 3, 2018FDA record creation date
Liquid Cardiac Control, CQ5052Z-0381-2019 · JJYRandox Laboratories Ltd.RecallNov 3, 2018FDA record creation date
Liquid Cardiac Control, CQ5053Z-0382-2019 · JJYRandox Laboratories Ltd.RecallNov 3, 2018FDA record creation date
Randox Calcium (Ca)K182042 · CJYRandox Laboratories, Ltd.510(k)Oct 23, 2018FDA decision date
Liquid Cardiac Control - Level 3, cat. no. CQ5053 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of…Z-2575-2018 · JJYRandox Laboratories Ltd.RecallJul 30, 2018FDA record creation date
Randox Liquid Assayed Specific Protein Control - Level 1 (SP Control 1), Cat. no. PS2682Z-2278-2018 · JJYRandox Laboratories Ltd.RecallJun 13, 2018FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗